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Solitary ﬁbrous tumor (SFT) is a rare spindle-cell neoplasm that can be found in the orbit. Here, we report
two cases affected by orbital SFT. Both patients were female, aged 52 years and 59 years, respectively, and
had experienced a painless unilateral orbital lesion. Computed tomography (CT) imaging revealed a well-
circumscribed and contrast-enhanced soft tissue mass simultaneously. The tumors were located in the
laterotemporal extraconal space of the right orbit and the inferior portion of the left orbit, respectively.
Both patients underwent complete resection of their tumors. The histological ﬁndings showed alter-
nating hypercellular and hypocellular areas composed of bland spindle cells with a ﬁbrous stroma. The
strong immunoreactivity for CD34 supported the diagnosis of orbital SFT. There was no recurrence at the
2-year and 3-year follow-up visits, respectively. SFTs should be considered in the differential diagnosis of
an orbital tumor. The combination of a CT scan, histologic ﬁndings, and immunohistochemical staining
will provide an accurate diagnosis. En bloc excision of the tumor is the mainstay of treatment in order to
avoid recurrence.
Copyright  2013, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Solitary ﬁbrous tumors (SFTs) arise from mesenchymal cells or
ﬁbroblasts. They usually present in the pleura, but recently a few
cases involving the orbit have been described.1,2 Patients with an
orbital SFT may present with unilateral, painless, slowly progres-
sive proptosis or a palpable mass in the periocular area. Computed
tomography (CT) scanning and magnetic resonance imaging (MRI)
reveal a well-circumscribed, contrast-enhanced soft tissue mass.3
Histological examination and positive CD34 immunoreactivity are
useful in discriminating SFTs from other tumors.4,5 Here, we report
two cases of orbital SFT.
2. Case reports
2.1. Case 1
A 52-year-old woman developed gradual proptosis of the right
eye over several months. On ophthalmic examination, her visual
acuity was 6/6.7 in the right eye. There was upward and laterallmology, Taichung Veterans
g Road, Taichung City 40705,
ei).
e Ophthalmologic Society of Taiwlimitation of right ocular movement. The lesion caused an inferior
displacement of the eyeball and exophthalmos (Fig. 1A). Hertel
exophthalmometry gave readings of 16.5 mm for the right eye and
13 mm for the left eye. CT scans revealed a contrast-enhanced
solitary mass located in the lateral extraconal space of the right
orbital cavity without bony erosion (Fig. 1B).
A lateral orbitotomy was performed. The mass was dissected
and excised completely (Fig. 1C). The bone fragment was then
replaced and secured with 3-0 nylon through pre-drilled holes.
In its gross dimensions, the lesion was a 3.8 cm  3 cm  1.5 cm,
thin, encapsulated, and well-circumscribed tumor. Microscopi-
cally, it revealed coexistent hypocellular and hypercellular areas
separated by ﬁbrous stroma (Fig. 1D and E). The hypercellular
areas were composed of bland spindle cells with a storiform
pattern. No mitotic activity or atypia cells were found. The
subsequent immunohistochemical staining revealed CD34 posi-
tivity (Fig. 1F), Ki-67 positivity of less than 5%, and S100 nega-
tivity. The patient was free of recurrence at a 2-year post-surgical
follow-up.
2.2. Case 2
A 59-year-old woman had developed a slowly progressing,
palpable, painlessmass over the infraorbital area of her left eye over
the previous 3 years. Her visual acuity was 6/6.7 for the left eye.an. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A) Upper eyelid swelling, proptosis, and medial inferior deviation of the globe is noted in the patient’s right eye. (B) Coronal CT scan reveals a contrast-enhanced mass (*)
next to the lacrimal gland (arrow) in the lateral extraconal space of the right orbit, causing downward displacement of the globe. (C) The 3.5 cm mass is dissected and removed
completely. (D) Photomicrograph showing diffuse spindle cells and collagen deposition (magniﬁcation 200). (E) Histology reveals the deposition of abundant collagen ﬁbers and
hypercellular (arrowhead) and hypocellular (asterisk) areas (magniﬁcation 100). (F) Immunohistochemical staining shows positivity for CD34 (magniﬁcation 200).
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and Hertel exophthalmometry were unremarkable. CT scans
revealed a well-enhanced orbital mass located at the left inferior
aspect of the orbit (Fig. 2). The patient underwent anterior orbitot-
omy via the lower eyelid. A 2 cm 1.5 cm 1 cm, tan-colored, well-
circumscribed tumorwas dissected and completely removed. There
was no inﬁltrative margin or tumor necrosis.
Microscopically, alternating hypercellular and hypocellular
areas with thickened keloid-like collagen ﬁbers were seen. There
were no mitoses or cellular atypia. Immunohistochemical staining
revealed a strong positive reaction for CD34, but negative staining
for actin M851, S100, and AE1/AE3. Ki67 showed only 1% positivity.
There was no recurrence of the tumor at a 3-year post-surgical
follow-up.3. Discussion
SFTs are uncommon, benign, and slowly progressing spindle-
cell tumors. They were originally described on the mesothelial
surfaces of the pleura. In line with the hypothesized origin of the
tumor frommesenchymal cells with ﬁbroblastic proliferation, it has
been called a “localized mesothelioma.”1 However, the histogenesis
of SFT is still controversial. Recently, this tumor has been described
in extrapleural sites such as the upper airway tract, nasal and
paranasal sinuses, parotid and salivary glands, thyroid, lung,
mediastinum, pericardium, peritoneum, liver, spine, soft tissue, and
orbit.1 Orbital SFTs can affect any orbital space. Lesions arising from
lacrimal gland fossa, lacrimal sacs, conjunctivae, and sclerae have
also been reported.6e9
Fig. 2. Computed tomography shows a well-enhanced lesion over the inferior aspect
of the left orbital cavity (arrow).
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ture.1,2 Orbital SFTs affect a wide age range (9e76 years) of patients,
predominating in middle-aged adults. There is no obvious predi-
lection by sex. The most common clinical sign is unilateral painless
proptosis with an insidious onset over several months to years
(range: 6e84 months). In our study, both cases were middle-aged
women who presented with a progressive, painless, unilateral
orbital mass.
In our cases, the orbital SFTs were shown as well-circumscribed,
contrast-enhanced masses on CT imaging. The radiological ﬁndings
of orbital SFT have been described by Kim et al.3 Orbital SFTs appear
as well-circumscribed masses with moderate to intense enhance-
ment and mostly without characteristics of bony erosion on CT
scanning. On MRI scans, they demonstrate T1-weighted signal
isointensity and T2-weighted hypointensity. However, the radio-
logic features of orbital SFTs are rather nonspeciﬁc. It is difﬁcult to
differentiate them from highly vascular lesions such as hemangi-
omas, ﬁbrous histiocytomas, neuroﬁbromas, meningiomas, and
schwannomas.
The ﬁrst orbital SFTwas independently reported byWestra et al4
and Dorfman et al5 in 1994. They described the classic histopath-
ologic features and immunohistochemical characteristics of SFTs,
with alternating hypercellular and hypocellular areas of spindle
cells against a background of thick collagen bundles, and a
hemangiopericytoma-like pattern of vascularity.4,5,10 Moreover,
CD34 is believed to be the most important diagnostic marker for
SFT. SFT shows a strong and diffuse immunopositivity for CD34 (in
79e100% of cases), vimentin, and bcl-2, and immunonegativity for
keratin, cytokeratin, epithelial membrane antigen, S100, smooth
muscle actin, and desmin on immunohistochemical staining.4,11e13
Both of our cases showed a low Ki67 proliferative indexdless than
5% and only 1%, respectively. The Ki-67 index usually reacts in 0e2%
of spindle-cell nuclei in benign SFT. In malignant cases, the per-
centage of positively staining nuclei can be up to 40%.14
The mainstay of treatment of orbital SFTs is surgical resection.
Generally, orbital SFTs represent a benign disease, and most caseshave been treated by local excision. Both of our patients were free
of recurrence for several years after complete resection of their
tumor. However, local recurrence has been reported in nine cases in
the literature.1,2 These were mainly related to incomplete initial
excision and the increased mitotic activity of the tumor. Only one
case of malignant transformation with 8 years of follow-up has
been reported to date.15 The aggressive histologic pattern of the
tumor can include abnormal mitotic ﬁgures, cellular pleomor-
phism, and giant tumor cells.16e18
In conclusion, SFTs are rare but should be included in the dif-
ferential diagnosis of orbital tumors in a patient who presents with
a well-circumscribed and contrast-enhanced mass. The histologic
characteristics and immunohistochemical markers, including CD34
positivity, are important diagnostic tools in diagnosing an SFT.
Complete surgical excision with careful postoperative follow-up is
the mainstay of treatment.
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